Oscar Health's Financial Performance in 2024
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a notable player in healthcare technology, has announced impressive financial results for the fourth quarter and full year of 2024. Demonstrating remarkable growth, Oscar Health's total revenue amounted to $9.2 billion, reflecting a staggering 56.5% increase year-over-year. This growth is primarily attributed to an uptick in membership during the Open Enrollment period, alongside strong retention rates and new members enrolling in Special Enrollment Periods (SEPs).
Key Variables Contributing to the Growth
While the Medical Loss Ratio (MLR) saw a slight increase of 10 basis points to 81.7%, driven mainly by the growth in SEP membership, the healthcare provider managed to maintain overall utilization favorably. Furthermore, the Selling, General and Administrative (SG&A) Expense Ratio improved substantially, recording a 520-basis point decline to 19.1%. These enhancements in operational efficiency alongside higher revenues indicate Oscar's strategic maneuvers in a competitive market.
Adjusted EBITDA and Net Income Highlights
Oscar Health also reported an Adjusted EBITDA of $199.2 million, which is a notable improvement of $244.5 million year-over-year. The net income attributable to Oscar reached $25.4 million, marking a substantial increase of $296.2 million over the previous year. Such figures are compelling indicators of Oscar's capacity to deliver sustained and profitable growth.
Outlook for 2025: New Financial Metrics
With an eye towards the future, Oscar has introduced an optimistic outlook for 2025. The Company anticipates total revenue to range between $11.2 billion and $11.3 billion, an MLR between 80.7% and 81.7%, and expects to improve its SG&A Expense Ratio further to between 17.6% and 18.1%. Additionally, Oscar forecasts operating earnings of $225 million to $275 million, signifying its strong commitment to achieving financial objectives and operational stability.
Strategic Leadership Changes
A key aspect of Oscar's strategy is the addition of healthcare expert Janet Liang, who will step into a pivotal role as President of Oscar Health Insurance starting in late February 2025. With her rich experience from Kaiser Foundation Health Plan, Inc., Liang is poised to enhance Oscar’s insurance segment and drive further operational success.
Key Metrics and Non-GAAP Financial Metrics Summary
Oscar Health consistently reviews various metrics to gauge its performance and strategically plan for the future. These metrics are instrumental in evaluating the effectiveness of current strategies, financial projections, trends in business, and operational insights. Total Revenue is particularly significant, serving as a bellwether for the Company's growth trajectory. Likewise, understanding the Medical Loss Ratio remains crucial in assessing healthcare expenditures pertinent to net premiums.
Medical Loss Ratio and SG&A Expense Insights
The Medical Loss Ratio, which serves as an essential measure of medical expenses against net premiums, stands as a testament to Oscar’s efficient cost management strategies. In this light, the Company actively monitors its SG&A Expense ratio, ensuring that operational costs align favorably against burgeoning revenue.
Frequently Asked Questions
What were Oscar Health's total revenues for 2024?
The total revenue for Oscar Health in 2024 was $9.2 billion.
What is the outlook for Oscar Health in 2025?
Oscar Health anticipates revenue between $11.2 billion and $11.3 billion in 2025.
Who is the new President of Oscar Health Insurance?
Janet Liang has been appointed as the new President of Oscar Health Insurance.
How did Oscar's Adjusted EBITDA change in 2024?
Oscar reported an Adjusted EBITDA of $199.2 million, an increase of $244.5 million from the previous year.
What is Oscar's strategy for managing medical costs?
Oscar continuously evaluates its Medical Loss Ratio and maintains efficient operational strategies to manage medical expenses effectively.
